In the race to forge the next Keytruda from PD-(L)1xVEGF bispecific antibodies, Pfizer and the BioNTech-Bristol Myers Squibb alliance are split on how to position overall survival—the gold-standard ...
The U.S. Food and Drug Administration (FDA) is unlikely to renew the authorization granted to use Pfizer (NYSE:PFE) and BioNTech’s (BNTX) COVID-19 vaccine in young children this fall, The Guardian ...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Pfizer (PFE) and BioNTech SE (BNTX). According to TipRanks.com, Schott is a 4-star analyst with an average return of 4 ...
Pfizer showcased multiple late-breakers at the American Society of Clinical Oncology’s annual conference but its biggest data ...
2don MSNOpinion
Opportunities in the oncology market: Positioning for the next billion-dollar catalyst with BioNTech, Vidac Pharma, and Pfizer
Large Pipeline The first-quarter figures were sobering. BioNTech generated revenue of just EUR 118.1 million, a decline of ...
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a new agreement with the European Commission (EC) to supply 900 million doses of ...
Due to Pfizer’s underperformance relative to its peers over the past year, Wall Street analysts remain cautious about the ...
A German court found Wednesday that American pharmaceutical giant Pfizer and German firm BioNTech violated a patent to make their COVID-19 vaccine. Siding with Moderna, an American pharmaceutical firm ...
The CHMP’s recommendation will be reviewed by the European Commission (EC), which is expected to make its final decision soon. Pfizer and BioNTech have already initiated manufacturing of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results